OPCH Option Care: Company Value to Revenue Ratio

Public company logo of Option Care Health, Inc. (OPCH)

Experienced management under John Rademacher ensures strict control over costs and margins for Option Care Health (OPCH). The company's EV/Sales ratio demonstrates smooth dynamics, while the 990.71 metric indicates the status of the current valuation. Business stability is supported by exclusive ties with biopharmaceutical companies and integration into medical centers. The non-cyclical demand for home infusion therapy guarantees resilience to market shocks.

Option Care Health - OPCH EV/Sales Multiple (period 11/23/2025 - 11/20/2026)

OPCH (Option Care Health Inc): analytical breakdowns and indicator data

Fundamental company valuation:OPCH, Option Care Health, Inc.
Mass-produced product of Option Care

Investors assess asset quality via the enterprise value-to-revenue ratio, which allows for the measurement of a business's market price without distortions from debt load. By analyzing the EV/Sales history, one can determine how effectively Option Care Health (OPCH) monetizes the home therapy trend, offsetting narrow specialization risks through extensive network reach and insurance contracts.

Direct competitors

Enterprise Value-to-Revenue Multiple hcahealthcare.com|THC: EV/Sales Multiple|FMS - Total Company Value-to-Revenue Ratio|Company Value to Revenue SOLV|Encompass (EHC) - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Universal Health Services, Inc. (UHS)|DaVita Inc. - Company Value to Revenue Ratio|Enterprise Value-to-Revenue Ratio RadNet Corp RDNT|SGRY (Surgery Partners) - Enterprise Value to Sales Volume|PINC - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio America's Best Contacts & Eyeglasses EYE|PGNY: EV/Sales Multiple|ARDT (Ardent Health Partners) - Enterprise Value-to-Revenue Ratio|SEM (selectmedical.com) - EV/Sales Multiple|Enterprise Value-to-Revenue Ratio ASTH|EV/Sales Multiple MD|Enterprise Value-to-Revenue Ratio USPH (US Physical Therapy Inc)|Enterprise Value-to-Revenue Ratio The Pennant Group, Inc. PNTG|Business Value to Revenue ORGO|NUTX - Enterprise Value-to-Revenue Ratio|AUNA - EV/Sales Multiple|SBC Medical Group Inc (SBC) - Enterprise Value-to-Revenue Ratio|EOLS: Enterprise Value-to-Revenue Coefficient|Enterprise Value-to-Revenue Ratio chs.net|SKIN: Business Value to Revenue|EV/Sales Multiple MDWD|BTMD - Enterprise Value-to-Revenue Multiple|The Joint Chiropractic - Company Value to Revenue|Enterprise Value-to-Revenue Coefficient DCGO (DocGo, Inc)|Total Company Value-to-Revenue Ratio PIII (p3hp.org)|GANX (Gain Therapeutics) - Company Value to Revenue Ratio|euda.com (EUDA) - Enterprise Value-to-Revenue Ratio|Company Value to Revenue Basel Medical|CLGN (CollPlant Biotechnologies) - EV/Sales Multiple|EV/Sales Multiple Cuprina Holdings Limited|Enterprise Value-to-Revenue Ratio concordmedical.com (CCM)|Enterprise Value-to-Revenue Ratio AMS (American Shared Hospital)|Enterprise Value-to-Revenue Ratio MEDIROM Corp MRM|EV/Sales Multiple avalon-globocare.com ALBT|DHAI - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio Longevity Health Holdings XAGE|NIVF (NewGenIvf Group Limited) - Company Value to Revenue|ATI Physical Therapy Inc. - Business Value to Revenue|CMAX (caremax.com) - EV/Sales Multiple|KDLY (Kindly MD Inc) - Enterprise Value-to-Revenue Coefficient|Enterprise Value-to-Revenue Ratio ModivCare Corp (MODV)|Total Company Value-to-Revenue Ratio Novo Integrated Sciences|SunLink Health Systems, Inc. - Company Value to Revenue|imacholdings.comm (BACK) - Enterprise Value-to-Revenue Multiple